Schwangerschaft und Schlaganfall

Zusammenfassung

Die Inzidenz eines Schlaganfalls bei Schwangeren bzw. in der Postpartalperiode ist mit 25 – 34 Fällen pro 100 000 erhöht. Wichtige Ursachen sind dabei Präeklampsie, Eklampsie, Sinus- und Venenthrombose sowie das reversible zerebrale Vasokonstriktionssyndrom (Postpartum-Angiopathie). Die thrombotische thrombozytopenische Purpura (TTP) und die Sichelzellanämie manifestieren sich oft erstmals in der Schwangerschaft. Entscheidend sind die rasche Diagnosestellung und das gezielte interdisziplinäre Management der Patientinnen. Die Thrombolyse während der Schwangerschaft gilt ebenso wie die endovaskuläre Schlaganfallbehandlung als individueller Heilversuch.

Abstract

There is an increased incidence of stroke during pregnancy of 25 to 34 per 100.000. Important causes include preeclampsia, eclampsia, sinus- and vein thrombosis as well as the reversible cerebral vasoconstriction syndrome (RCVS, post partum angiopathy). Thrombotic thrombocytopenic purpura (TTP) and sickle cell anemia are coagulopathies which often manifest during pregnancy for the first time. Important are the early diagnosis and a focused interdisciplinary management of these patients. Intravenous thrombolysis and endovascular thrombectomy are individual treatment options during pregnancy.

Schlüsselwörter

Schlaganfall - Schwangerschaft - Sinusthrombose - Eklampsie - RCVS

Keywords

stroke - pregnancy - sinus thrombosis - eclampsia - RCVS

• Literatur

• 1 Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245
• 2 Seshadri S, Beiser A, Kelly-Hayes M et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345-350
• 3 Lamy C, Sharshar T, Mas JL. [Cerebrovascular diseases in pregnancy and puerperium]. Revue neurologique 1996; 152: 422-440
• 4 James AH, Bushnell CD, Jamison MG et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509-516
• 5 Kittner SJ, Stern BJ, Feeser BR et al. Pregnancy and the risk of stroke. N Eng J Med 1996; 335: 768-774
• 6 Lanska DJ, Kryscio RJ. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 1998; 51: 1622-1628
• 7 Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31: 1274-1282
• 8 Bateman BT, Schumacher HC, Bushnell CD et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 2006; 67: 424-429
• 9 Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995; 26: 930-936
• 10 Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 2000; 31: 2948-2951
• 11 Cnossen JS, Vollebregt KC, de Vrieze N et al. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ 2008; 336: 1117-1120
• 12 Schaefer PW, Buonanno FS, Gonzalez RG et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28: 1082-1085
• 13 Fletcher JJ, Kramer AH, Bleck TP et al. Overlapping features of eclampsia and postpartum angiopathy. Neurocrit care 2009; 11: 199-209
• 14 Crovetto F, Somigliana E, Peguero A et al. Stroke during pregnancy and pre-eclampsia. Current opinion in obstetrics & gynecology 2013; 25: 425-432
• 15 Sawle GV, Ramsay MM. The neurology of pregnancy. J Neurol Neurosurg and Psychiatry 1998; 64: 711-725
• 16 [Anonym]. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-1463
• 17 Kramer MS, Rouleau J, Baskett TF et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006; 368: 1444-1448
• 18 Fugate JE, Ameriso SF, Ortiz G et al. Variable presentations of postpartum angiopathy. Stroke 2012; 43: 670-676
• 19 Call GK, Fleming MC, Sealfon S et al. Reversible cerebral segmental vasoconstriction. Stroke 1988; 19: 1159-1170
• 20 Raps EC, Galetta SL, Broderick M et al. Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol 1993; 33: 222-225
• 21 Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care 2005; 3: 91-97
• 22 Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency. Ther Adv Neurol Disord 2010; 3: 161-171
• 23 Canhao P, Ferro JM, Lindgren AG et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36: 1720-1725
• 24 Einhaupl K, Stam J, Bousser MG et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17: 1229-1235
• 25 Sipes SL, Malee MP. Endocrine disorders in pregnancy. Obstet Gynecol Clin North Am 1992; 19: 655-677
• 26 Harbeck B, Schutt M, Sayk F. [Endocrine emergencies during pregnancy]. Med Klin Intensivmed Notfallmed 2012; 107: 110-117
• 27 Leonhardt G, Gaul C, Nietsch HH et al. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006; 21: 271-276
• 28 Murugappan A, Coplin WM, Al-Sadat AN et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 2006; 66: 768-770
• 29 Broderick JP. Should intravenous thrombolysis be considered the first option in pregnant women?. Stroke 2013; 44: 866-867